Medical & Clinical Reviews

contact@imedpub.com Submit a Manuscript

Substandard And Counterfeit Medicines Scholarly Journal

There is no clear, agreed international definition of counterfeit medicines.The most widely used definition in the literature, in the last two decades, is that given in 1992 by the WHO.This defines a counterfeit medicine as a medicine which is deliberately and fraudulently mislabelled with respect to identity and/or source. Counterfeiting can apply to branded and generic products. Counterfeit products may include the following: the correct ingredients, the wrong ingredients, no active ingredients, insufficient ingredients or fake packaging (ie, misleading about its origin or authenticity).Substandard medicines are defined as genuine medicines which have failed to pass the quality measurements and standards set for them. These quality standard tests have been derived from the official pharmacopoeias.In 2011, the WHO member states chose to include counterfeit and substandard medicines under the new term ‘substandard/spurious/falsely-labelled/falsified/counterfeit medical products’ (SSFFC). This new term, however, has been questioned recently as it is felt not to distinguish sufficiently between the different illegitimate drug categories (such as counterfeit and substandard) that require different monitoring and solutions.

 

High Impact List of Articles
Conference Proceedings

Relevant Topics in Medical Sciences

Awards Nomination 17+ Million Readerbase
Google Scholar citation report
Citations : 906

Medical & Clinical Reviews received 906 citations as per Google Scholar report

image
Medical & Clinical Reviews peer review process verified at publons
image
Abstracted/Indexed in
  • Google Scholar
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Publons
  • Secret Search Engine Labs

View More »

Open Access Journals